Skip to content

Helping Those With Mental Illness Quit Smoking

Preparing Those With Significant and Persistent Mental Illness to Quit Smoking

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01783912
Enrollment
270
Registered
2013-02-05
Start date
2012-12-31
Completion date
2014-06-30
Last updated
2016-02-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Disorders, Nicotine Dependence, Smoking

Keywords

Smoking, Nicotine Dependence, Mental Disorders

Brief summary

This study tests whether pre-cessation interventions known to be effective in the general population will increase acceptance of evidence-based treatment, engagement and compliance with that treatment and initial quitting success. One hundred and seventy two patients will be recruited from 13 Community Support Programs (CSPs). CSPs provide community based care to those diagnosed with persistent and serious mental illness. All participants will receive two group sessions (40 minutes each) modeled after Kicking Butts, a group-based quitting preparation program used for the past four years in two Milwaukee CSP programs run by Wisconsin Community Services. Individuals will then be randomly assigned to the experimental and control conditions (n=86 each). Experimental subjects will receive four evidence-based preparatory interventions (motivational interviewing, smoking reduction, practice quit attempt, and pre-quit use of nicotine replacement medication) (25 - 30 minutes each). Attention control subjects will also receive four individual sessions of the same duration. However their individual sessions' content will be a discussion of the personal relevance of the group material and will not include any of the preparatory interventions. Data will be collected via brief surveys taken pre-intervention, at the end of the last individual session, and three months later and from a database provided by the Wisconsin Tobacco Quit Line (WTQL).

Interventions

BEHAVIORALCognitive / Motivational Individual Sessions

Cognitive Motivational subjects will receive four evidence-based preparatory interventions (motivational interviewing, smoking reduction, practice quit attempt, and pre-quit use of nicotine replacement medication) (25 - 30 minutes each).

BEHAVIORALAttention Control Individual Sessions

Attention control subjects will receive four placebo individual sessions (25-30 minutes each). The session content will reemphasize group discussion of the personal health risks from smoking.

DRUGNicotine Patch

Cognitive Motivational subjects will be asked to take one 21 mg patch/day for 4 weeks.

BEHAVIORALGroup Curriculum

Everyone to be put into the experimental or active comparator group will attend 2 group meetings over two weeks each of which lasts 40 minutes. Experience with the Kicking Butts program indicates that this duration is well tolerated by this population. The content of these two group meetings is based on the Kicking Butts program. The Kicking Butts program was initially developed as a cessation intervention, but consistent with the literature about the need to prepare this population to make a quit attempt, has evolved to emphasize preparation for quitting. Topics addressed include the health consequences of smoking, reasons to quit and methods of quitting.

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* current smoker (smoking daily or smoking at least 10 cigarettes per week) (use of other tobacco products permitted such as chew and snuz in addition to smoking) * not willing to make a quit attempt * willingness to use the nicotine patch * plans to remain in the area for the next five four months.

Exclusion criteria

* current use of any cessation medicine (nicotine patch, nicotine gum, nicotine lozenge, nicotine inhaler, nicotine nasal spray, bupropion, Wellbutrin, Zyban,Chantix or varenicline) * previous serious skin reaction or other allergic reaction to using the nicotine patch * stroke, heart attack or abnormal electrocardiogram in past four weeks * pregnancy, plans to get pregnant or nursing * exclusive use of other tobacco products (non-smoker tobacco user) * having a court-ordered guardian, or an activated power of attorney for health or observation by researchers during the consent procedure that suggests diminished decision making capacity

Design outcomes

Primary

MeasureTime frameDescription
Acceptance of Wisconsin Tobacco Quit Line Services4-6 weeks after study enrollmentThe primary outcome is participant acceptance of evidence based treatment through the WTQL at the end of the last individual session.

Countries

United States

Participant flow

Participants by arm

ArmCount
Cognitive/Motivational Intervention Group
This arm of the project will address the following questions: After completion of experimental individual sessions, do the participants in the control group utilize the quit line services at the same, greater or lesser rate than those who are in the Active Control group? After completion of experimental individual sessions, do the participants in the control group utilize the quit line services at the same, greater or lesser rate than those who are in the Motivated Smokers Comparison group? Cognitive / Motivational Individual Sessions: Cognitive Motivational subjects will receive four evidence-based preparatory interventions (motivational interviewing, smoking reduction, practice quit attempt, and pre-quit use of nicotine replacement medication) (25 - 30 minutes each). Nicotine Patch: Cognitive Motivational subjects will be asked to take one 21 mg patch/day for 4 weeks.
118
Attention Control Group
This arm of the project will address the following question: After completion of control individual sessions, do the participants in the control group utilize the quit line services at the same, greater or lesser rate that those who are in the experimental treatment group? After completion of control individual sessions, do the participants in the control group utilize the quit line services at the same, greater or lesser rate than those who are in the Cognitive/Motivational Intervention Group? Attention Control Individual Sessions: Attention control subjects will receive four placebo individual sessions (25-30 minutes each). The session content will reemphasize group discussion of the personal health risks from smoking.
104
Motivated Smokers Comparison Group
This arm of the project will address the following question: Do participants in the Motivated Smokers Comparison group (identified as motivated to quit upon recruitment) utilize the quit line services at the same, greater or lesser rate than those who are in the Motivated Smokers Comparison group? Do participants in the Motivated Smokers Comparison group (identified as motivated to quit upon recruitment) utilize the quit line services at the same, greater or lesser rate than those who are in the Active Control group? Participants will not receive any intervention but will be consented and enrolled into this group and assessed for utilization of the tobacco quit line services.
48
Total270

Baseline characteristics

CharacteristicCognitive/Motivational Intervention GroupAttention Control GroupMotivated Smokers Comparison GroupTotal
Age, Continuous43.8 years
STANDARD_DEVIATION 9.88
43.6 years
STANDARD_DEVIATION 10.05
45.0 years
STANDARD_DEVIATION 9.54
44.0 years
STANDARD_DEVIATION 9.87
Region of Enrollment
United States
118 participants104 participants48 participants270 participants
Sex: Female, Male
Female
58 Participants48 Participants24 Participants130 Participants
Sex: Female, Male
Male
60 Participants56 Participants24 Participants140 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 1180 / 1040 / 48
serious
Total, serious adverse events
0 / 1180 / 1040 / 48

Outcome results

Primary

Acceptance of Wisconsin Tobacco Quit Line Services

The primary outcome is participant acceptance of evidence based treatment through the WTQL at the end of the last individual session.

Time frame: 4-6 weeks after study enrollment

ArmMeasureValue (NUMBER)
Cognitive/Motivational Intervention GroupAcceptance of Wisconsin Tobacco Quit Line Services11 participants
Attention Control GroupAcceptance of Wisconsin Tobacco Quit Line Services6 participants
Motivated Smokers Comparison GroupAcceptance of Wisconsin Tobacco Quit Line Services6 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026